Nir Ben-Chetrit

Nir Ben-Chetrit

Auto-generated profile, based on publicly available information

Nir Ben-Chetrit

Weill Cornell Medicine

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2023 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
NBNir Ben-Chetrit
Nir Ben-Chetrit
XNXiang Niu
Xiang Niu
ASAriel D. Swett
Ariel D. Swett
JSJesus Sotelo
Jesus Sotelo
MJMaria S. Jiao
Maria S. Jiao
DLDan A. Landau
Dan A. Landau

18 March 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
NBNir Ben-Chetrit
Nir Ben-Chetrit
XNXiang Niu
Xiang Niu
ASAriel D. Swett
Ariel D. Swett
JSJesus Sotelo
Jesus Sotelo
MJMaria S. Jiao
Maria S. Jiao
DLDan Avi Landau
Dan Avi Landau
Spatial transcriptomics and proteomics have independently transformed our understanding of complex biological processes; however, integration of these modalities is currently limited. To overcome this challenge, we developed S patial P r O tein and T ranscriptome S equencing (SPOTS) for high-throughput integration of transcriptome and protein profiling within the spatial context. Applying SPOTS to spleen and breast cancer samples revealed that spatially-resolved multi-omic integration provides a comprehensive perspective on key biological processes in health and disease.

27 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
NBNir Ben-Chetrit
Nir Ben-Chetrit
XNXiang Niu
Xiang Niu
JSJesus Sotelo
Jesus Sotelo
ASAriel D. Swett
Ariel D. Swett
VRVinagolu K. Rajasekhar
Vinagolu K. Rajasekhar
DLDan A. Landau
Dan A. Landau
Summary: Tumor-infiltrating macrophages support critical steps in tumor progression, and their accumulation in the tumor microenvironment (TME) is associated with adverse outcomes and therapeutic resistance across human cancers. In the TME, macrophages adopt diverse phenotypic alterations, giving rise to heterogeneous immune activation states and induction of cell cycle. While the transcriptional profiles of these activation states are well-annotated across human cancers, the underlying signals that regulate macrophage heterogeneity and accumulation remain incompletely understood. Here, we leveraged a novel ex vivo organotypic TME (oTME) model of breast cancer, in vivo murine models, and human samples to map the determinants of functional heterogeneity of TME macrophages. We identified a subset of F4/80 high Sca-1+ self-renewing macrophages maintained by type-I interferon (IFN) signaling and requiring physical contact with cancer-associated fibroblasts. We discovered that the contact-dependent self-renewal of TME macrophages is mediated via Notch4, and its inhibition abrogated tumor growth of breast and ovarian carcinomas in vivo , as well as lung dissemination in a PDX model of triple-negative breast cancer (TNBC). Through spatial multi-omic profiling of protein markers and transcriptomes, we found that the localization of macrophages further dictates functionally distinct but reversible phenotypes, regardless of their ontogeny. Whereas immune-stimulatory macrophages (CD11C+CD86+) populated the tumor epithelial nests, the stroma-associated macrophages (SAMs) were proliferative, immunosuppressive (Sca-1+CD206+PD-L1+), resistant to CSF-1R depletion, and associated with worse patient outcomes. Notably, following cessation of CSF-1R depletion, macrophages rebounded primarily to the SAM phenotype, which was associated with accelerated growth of mammary tumors. Our work reveals the spatial determinants of macrophage heterogeneity in breast cancer and highlights the disruption of macrophage self-renewal as a potential new therapeutic strategy.